Methylenedioxypyrovalerone (MDPV) is usually a stimulant with the cathinone course that acts to be a norepinephrine–dopamine reuptake inhibitor (NDRI). It was initial designed during the sixties by a staff at Boehringer Ingelheim. Its activity in the dopamine transporter is 6 periods much better than with the norepinephrine transporter and it is